肝细胞癌：全面综述。
Hepatocellular carcinoma: A comprehensive review.
作者信息
Waller Lisa P, Deshpande Vrushak, Pyrsopoulos Nikolaos
机构信息
Lisa P Waller, Vrushak Deshpande, Nikolaos Pyrsopoulos, Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, Newark, NJ 07103, United States.
出版信息
World J Hepatol. 2015 Nov 18;7(26):2648-63. doi: 10.4254/wjh.v7.i26.2648.
Abstract
Hepatocellular carcinoma (HCC) is rapidly becoming one of the most prevalent cancers worldwide. With a rising rate, it is a prominent source of mortality. Patients with advanced fibrosis, predominantly cirrhosis and hepatitis B are predisposed to developing HCC. Individuals with chronic hepatitis B and C infections are most commonly afflicted. Different therapeutic options, including liver resection, transplantation, systemic and local therapy, must be tailored to each patient. Liver transplantation offers leading results to achieve a cure. The Milan criteria is acknowledged as the model to classify the individuals that meet requirements to undergo transplantation. Mean survival remains suboptimal because of long waiting times and limited donor organ resources. Recent debates involve expansion of these criteria to create options for patients with HCC to increase overall survival.
摘要
肝细胞癌（HCC）正迅速成为全球最常见的癌症之一。随着发病率的上升，它是一个突出的死亡原因。晚期纤维化患者，主要是肝硬化和乙型肝炎患者，易患HCC。慢性乙型和丙型肝炎感染的个体最常受到影响。不同的治疗选择，包括肝切除、移植、全身和局部治疗，必须根据每个患者量身定制。肝移植提供了实现治愈的领先结果。米兰标准被公认为对符合移植要求的个体进行分类的模型。由于等待时间长和供体器官资源有限，平均生存率仍然不理想。最近的争论涉及扩大这些标准，为HCC患者创造选择以提高总体生存率。
相似文献
1
Hepatocellular carcinoma: A comprehensive review.肝细胞癌：全面综述。
World J Hepatol. 2015 Nov 18;7(26):2648-63. doi: 10.4254/wjh.v7.i26.2648.
2
Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.对超出米兰标准的肝细胞癌患者进行降期治疗：使用载药微球化疗栓塞的策略
J Vasc Interv Radiol. 2013 Nov;24(11):1613-22. doi: 10.1016/j.jvir.2013.07.024. Epub 2013 Sep 20.
3
Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.超出米兰或加州大学旧金山分校标准的肝细胞癌活体肝移植结果
Indian J Surg. 2015 Dec;77(Suppl 3):950-6. doi: 10.1007/s12262-014-1078-6. Epub 2014 Apr 24.
4
Liver transplantation for hepatocellular carcinoma: Korean experience.肝移植治疗肝细胞癌：韩国经验。
J Hepatobiliary Pancreat Sci. 2010 Sep;17(5):539-47. doi: 10.1007/s00534-009-0167-6. Epub 2009 Sep 2.
5
Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma.肝细胞癌活体肝移植预后的预测因素
Indian J Surg. 2017 Aug;79(4):299-307. doi: 10.1007/s12262-016-1474-1. Epub 2016 Apr 7.
6
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.米兰标准外肝癌患者行肝移植与部分肝切除术后结局的对比分析。
Am J Clin Oncol. 2011 Oct;34(5):466-71. doi: 10.1097/COC.0b013e3181ec63dd.
7
Liver resection and transplantation in the management of hepatocellular carcinoma: a review.肝细胞癌治疗中肝切除与肝移植的综述
Exp Clin Transplant. 2006 Dec;4(2):549-58.
8
Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.米兰标准与加州大学旧金山分校标准下肝细胞癌肝移植的比较研究
Eur J Gastroenterol Hepatol. 2018 Apr;30(4):398-403. doi: 10.1097/MEG.0000000000001044.
9
Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience.肝细胞癌降期和桥接治疗对肝移植术后生存的影响：单中心经验
Exp Clin Transplant. 2017 Mar;15(Suppl 2):7-11. doi: 10.6002/ect.TOND16.L4.
10
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
引用本文的文献
1
EIF4A3-Mediated downregulation of circPTEN promotes hepatocellular carcinoma progression through the miR-1289/RBM38 Axis.EIF4A3介导的circPTEN下调通过miR-1289/RBM38轴促进肝细胞癌进展。
J Mol Histol. 2025 Jun 17;56(4):196. doi: 10.1007/s10735-025-10473-9.
2
Twenty-five years of WWOX insight in cancer: a treasure trove of knowledge.WWOX在癌症研究领域的25年洞察：知识宝库
Funct Integr Genomics. 2025 May 6;25(1):100. doi: 10.1007/s10142-025-01601-5.
3
Development of HepatIA: A computed tomography annotation platform and database for artificial intelligence training in hepatocellular carcinoma detection at a Brazilian tertiary teaching hospital.HepatIA 的开发：一个用于巴西三级教学医院肝细胞癌检测人工智能训练的计算机断层扫描注释平台和数据库。
Clinics (Sao Paulo). 2024 Oct 9;79:100512. doi: 10.1016/j.clinsp.2024.100512. eCollection 2024.
4
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular cancer-a narrative review and expert opinion.肝细胞癌患者的立体定向体部放射治疗——叙述性综述与专家意见
J Gastrointest Oncol. 2024 Aug 31;15(4):1880-1892. doi: 10.21037/jgo-23-771. Epub 2024 Feb 2.
5
A Multi-Scale Liver Tumor Segmentation Method Based on Residual and Hybrid Attention Enhanced Network with Contextual Integration.基于残差和混合注意力增强网络与上下文集成的多尺度肝脏肿瘤分割方法。
Sensors (Basel). 2024 Sep 9;24(17):5845. doi: 10.3390/s24175845.
6
A genomic and bioinformatic-based approach to identify genetic variants for liver cancer across multiple continents.一种基于基因组学和生物信息学的方法，用于在多个大洲识别肝癌的遗传变异。
Genomics Inform. 2023 Dec;21(4):e48. doi: 10.5808/gi.23067. Epub 2023 Dec 29.
7
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity.环孢素抑制剂 Rencofilstat 可降低 HCV 诱导的肝细胞癌，而与其抗病毒活性无关。
Viruses. 2023 Oct 17;15(10):2099. doi: 10.3390/v15102099.
8
The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability.肝细胞癌中的细胞外基质：机制与治疗弱点。
Cell Rep Med. 2023 Sep 19;4(9):101170. doi: 10.1016/j.xcrm.2023.101170. Epub 2023 Aug 30.
9
Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma.泛素特异性肽酶2a在肝细胞癌发病机制中的失调与致癌活性
Am J Cancer Res. 2023 Jun 15;13(6):2392-2409. eCollection 2023.
10
Recombinant ferritins for multimodal nanomedicine.用于多模式纳米医学的重组铁蛋白。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2219868. doi: 10.1080/14756366.2023.2219868.
本文引用的文献
1
The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.肿瘤大小对孤立性肝细胞癌切除术后长期生存结果的影响：单机构2558例患者的经验
J Gastrointest Surg. 2015 Jul;19(7):1281-90. doi: 10.1007/s11605-015-2849-5. Epub 2015 May 9.
2
Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study.基于炎症指标的动态变化预测肝细胞癌化疗栓塞术后死亡率：一项前瞻性研究。
Aliment Pharmacol Ther. 2014 Dec;40(11-12):1270-81. doi: 10.1111/apt.12992. Epub 2014 Oct 18.
3
Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.非酒精性脂肪性肝病中的肝细胞癌：环境与遗传因素的作用
World J Gastroenterol. 2014 Sep 28;20(36):12945-55. doi: 10.3748/wjg.v20.i36.12945.
4
Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria.综述文章：肝细胞癌的肝移植——对当前全球列入标准的批判性评估
Aliment Pharmacol Ther. 2014 Oct;40(8):893-902. doi: 10.1111/apt.12922. Epub 2014 Aug 26.
5
Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies.肝细胞癌：未来治疗中致癌作用的新型分子靶点
Biomed Res Int. 2014;2014:203693. doi: 10.1155/2014/203693. Epub 2014 Jun 25.
6
[Usefulness of the molecular profile in the diagnosis, prognosis and treatment of hepatocellular carcinoma].[分子图谱在肝细胞癌诊断、预后及治疗中的应用价值]
Gastroenterol Hepatol. 2014 Jul;37 Suppl 2:81-9. doi: 10.1016/S0210-5705(14)70074-3.
7
LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.LI-RADS（肝脏成像报告和数据系统）：LI-RADS 管理工作组的总结、讨论和共识，以及未来方向。
Hepatology. 2015 Mar;61(3):1056-65. doi: 10.1002/hep.27304. Epub 2014 Dec 12.
8
Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer.局部晚期不可切除结直肠癌患者基于炎症的预后评分和营养预后指数
World J Surg Oncol. 2014 Jul 15;12:210. doi: 10.1186/1477-7819-12-210.
9
Living donor liver transplantation for patients with hepatocellular carcinoma.肝细胞癌患者的活体供肝肝移植
Liver Cancer. 2014 May;3(2):108-18. doi: 10.1159/000343866.
10
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.雷帕霉素哺乳动物靶点抑制剂与肝移植后肝细胞癌复发率较低相关：一项系统评价
Transpl Int. 2014 Oct;27(10):1039-49. doi: 10.1111/tri.12372. Epub 2014 Jul 18.
Zotero 插件